Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

AIDS development can be monitored and predicted

11.09.2003


Total lymphocyte count and hemoglobin concentration lowers at onset of the disease



People with HIV and their physicians could have a less expensive tool to track the progression from HIV infection to AIDS. According to researchers from the Johns Hopkins Bloomberg School of Public Health, a decline in the total lymphocyte counts (TLC) and hemoglobin (Hgb) concentration in the blood may be used to monitor a patient’s disease status. Currently, HIV RNA and CD4+ cells in the blood are measured. However, specialized equipment and training for lab technicians makes these measurements expensive. TLC and Hgb measurements are much less expensive and can be obtained by using standard blood tests. "Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men," appears in the September 2003 issue of the journal AIDS, the official journal of the International AIDS Society.

The study’s lead author, Bryan Lau, a graduate student in the School’s Department of Epidemiology, said, "This study demonstrates that there is a biological event that occurs during the progression of HIV infection leading to declines in TLC and Hgb within individuals. The majority of HIV individuals who develop AIDS experience a rapid decline in total lymphocyte counts and hemoglobin concentration that starts about one and one-half years prior to developing AIDS. The decline in these two markers in individuals who develop AIDS shows that this is an important event in the pathogenesis of the disease."


The study authors analyzed longitudinal measurements of TLC and Hgb in 3,299 homosexual and bisexual men enrolled in the Multicenter AIDS Cohort Study (MACS) from 1984-1991. The researchers found that for many years after HIV infection, TLC and Hgb markers are stable and provide little information about HIV disease progression to AIDS.

However, as HIV disease progresses, TLC and Hgb begin to decline rapidly. A TLC decline greater than 10 percent per year and Hgb decline greater than 2.2 percent per year was present in over 77 percent of the study participants who developed AIDS and absent from over 78 percent of individuals who did not develop AIDS.

To further support their findings, the researchers explain in their study that current World Health Organization guidelines suggest the use of TLC measurements for monitoring an individual’s HIV infection in developing countries if CD4+ cell counts are not known. Hgb levels have also been shown to have an association with progression from asymptomatic HIV infection to AIDS.

Currently, in order to begin antiretroviral therapy for asymptomatic HIV-infected individuals, measurements of HIV RNA levels and CD4+ lymphocyte counts in the blood are required. These measurements are expensive and require technological expertise and equipment that is typically not available in developing countries.

Joseph Margolick, a contributing author and professor in the School’s Department of Molecular Microbiology and Immunology, said, "These results could be very useful for regions with scarce heath-care resources as an alternative way of identifying individuals who should receive drug therapy for HIV infection. We believe further research in appropriate populations is warranted."


Stephen J. Gange, Adjunct Associate Professor in the School’s Department of Epidemiology, and Joseph B. Margolick, Professor in the Department of Molecular Microbiology and Immunology, co-authored the study. Additional co-authors are John P. Phair, with Northwestern University Medical School, Sharon A. Riddler, with the University of Pittsburgh, and Roger Detels, with UCLA’s School of Public Health.

The MACS is funded by the National Institute of Allergy and Infectious Diseases and the National Cancer Institute.

Kenna Brigham | EurekAlert!
Further information:
http://www.jhsph.edu

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>